AngioDynamics | ANGO - Sales Revenues


AngioDynamics reported $79.43M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 154.45M 850K Sep/2026
Boston Scientific USD 5.14B 300M Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
ICU Medical USD 556.22M 4.54M Sep/2026
Inogen USD 74.93M 504K Sep/2024
J&J USD 25.4B 89M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Merit Medical Systems USD 416.24M 2.56M Sep/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Smiths GBP 1.02B 420M Jul/2026
Tandem Diabetes Care USD 283.69M 29.09M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
Terumo JPY 311.81B 11.49B Jun/2026
Trinity Biotech USD 10.85M 226K Mar/2026